116 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
50
Discovery of potent and selective inhibitors of human aminopeptidases ERAP1 and ERAP2 by screening libraries of phosphorus-containing amino acid and dipeptide analogues.
Wroclaw University of Technology
30
A structural insight into the P1S1 binding mode of diaminoethylphosphonic and phosphinic acids, selective inhibitors of alanine aminopeptidases.
Wroclaw University of Technology
33
Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.
Shandong University
21
Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
Fudan University
11
Influence of polar side chains modifications on the dual enkephalinase inhibitory activity and conformation of human opiorphin, a pain perception related peptide.
Institute of Advanced Chemistry of Catalonia (Iqac-Csic)
4
Modulation of disulfide dual ENKephalinase inhibitors (DENKIs) activity by a transient N-protection for pain alleviation by oral route.
Pharmaleads
8
Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.
Shandong University
39
Exploring S1 plasticity and probing S1' subsite of mammalian aminopeptidase N/CD13 with highly potent and selective aminobenzosuberone inhibitors.
University of Upper Alsace
19
Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases.
University of Athens
18
New orally active dual enkephalinase inhibitors (DENKIs) for central and peripheral pain treatment.
Pharmaleads
26
Design, synthesis and preliminary evaluation ofa-sulfonyl¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.
Shandong University
7
Synthesis of amino-hydroxy-benzocycloheptenones as potent, selective, non-peptidic dinuclear zinc metalloaminopeptidase inhibitors.
University of Upper Alsace
15
Novelß-dicarbonyl derivatives as inhibitors of aminopeptidase N (APN).
Shandong University
1
Solid phase synthesis and biological evaluation of probestin as an angiogenesis inhibitor.
The University of Oklahoma Health Sciences Center
2
Discovery of a synthetic Aminopeptidase N inhibitor LB-4b as a potential anticancer agent.
Shandong University
20
Novel indoline-2,3-dione derivatives as inhibitors of aminopeptidase N (APN).
Shandong University
3
Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy.
University of Upper Alsace
22
Novel leucine ureido derivatives as inhibitors of aminopeptidase N (APN).
Shandong University
12
The replacement of His(4) in angiotensin IV by conformationally constrained residues provides highly potent and selective analogues.
Vrije Universiteit Brussel
32
Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis.
TBA
14
Structure-activity relationships and blood distribution of antiplasmodial aminopeptidase-1 inhibitors.
University of Lille
12
Rapid and efficient synthesis of a novel series of substituted aminobenzosuberone derivatives as potent, selective, non-peptidic neutral aminopeptidase inhibitors.
University of Upper Alsace
25
A novel aminopeptidase N inhibitor developed by virtual screening approach.
Shandong Academy of Sciences
21
Remarkable potential of thea-aminophosphonate/phosphinate structural motif in medicinal chemistry.
Wroclaw University of Technology
26
Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors.
Shandong University
8
Proposed Bioactive Conformations of Opiorphin, an Endogenous Dual APN/NEP Inhibitor.
TBA
22
Structure-activity relationship study of opiorphin, a human dual ectopeptidase inhibitor with antinociceptive properties.
Institute of Advanced Chemistry of Catalonia (Iqac-Csic)
16
Inhibitors of bacterial N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) and demonstration of in vitro antimicrobial activity.
Loyola University
25
Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).
Shandong University
21
Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).
Shandong University
7
Synthesis, biological evaluation and structural determination of beta-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors.
Korea Research Institute of Chemical Technology
3
N-hydroxy-2-(naphthalene-2-ylsulfanyl)-acetamide, a novel hydroxamic acid-based inhibitor of aminopeptidase N and its anti-angiogenic activity.
Sejong University
11
The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
Wroclaw University of Technology
4
Long lasting antinociceptive properties of enkephalin degrading enzyme (NEP and APN) inhibitor prodrugs.
University of Paris
34
Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors: synthesis, biological properties, and antinociceptive activities.
University of Paris
33
Investigation of subsite preferences in aminopeptidase A (EC 3.4.11.7) led to the design of the first highly potent and selective inhibitors of this enzyme.
University of Paris
20
Investigation of the active site of aminopeptidase A using a series of new thiol-containing inhibitors.
University of Paris
23
Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation.
University of Paris
15
Analgesic dipeptide derivatives. 7. 3,7-Diamino-2-hydroxyheptanoic acid (DAHHA) containing dipeptide analogues of the analgesic compound H-Lys-Trp(Nps)-OMe.
Instituto De Qu£Mica M£Dica
15
Synthesis of sulfur-containing analogues of bestatin. Inhibition of aminopeptidases by alpha-thiolbestatin analogues.
University of Wisconsin
20
New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties.
TBA
13
Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes.
TBA
6
Design, synthesis and antimalarial activity of novel, quinoline-based, zinc metallo-aminopeptidase inhibitors.
University of Lille
22
Nonpeptide small-molecular inhibitors of dipeptidyl peptidase IV: N-phenylphthalimide analogs.
University of Tokyo
22
Design of the first highly potent and selective aminopeptidase N (EC 3.4.11.2) inhibitor.
University of Paris
20
Pseudopeptide inhibitors of aminopeptidases containing the [CH(CN)NH] surrogate as a transition-state MIMIC
TBA
9
Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
Central South University
23
Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.
Shandong University
12
A novel amino-benzosuberone derivative is a picomolar inhibitor of mammalian aminopeptidase N/CD13.
University of Upper Alsace
29
Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.
Shandong University
16
Potent macrocyclic inhibitors of insulin-regulated aminopeptidase (IRAP) by olefin ring-closing metathesis.
Uppsala University
40
Discovery ofß-aminoacyl containing thiazolidine derivatives as potent and selective dipeptidyl peptidase IV inhibitors.
Korea Research Institute of Chemical Technology
8
Chemical target validation studies of aminopeptidase in malaria parasites using alpha-aminoalkylphosphonate and phosphonopeptide inhibitors.
Trinity College
9
Amino-benzosuberone: a novel warhead for selective inhibition of human aminopeptidase-N/CD13.
Merck Sharpe and Dohme
27
Design, synthesis and biological evaluation of novel L-lysine ureido derivatives as aminopeptidase N inhibitors.
Shandong University
14
Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP).
Uppsala University
24
Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.
Shandong University
32
Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Structure-based design, chemistry and activity evaluation. II.
Shandong University
41
New aromatic monoesters of alpha-aminoaralkylphosphonic acids as inhibitors of aminopeptidase N/CD13.
Wroclaw University of Technology
28
Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.
Shandong University
31
Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.
Shandong University
27
Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Design, chemistry and activity evaluation. Part I.
Shandong University
26
Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.
Shandong University
26
Design and synthesis of novel chloramphenicol amine derivatives as potent aminopeptidase N (APN/CD13) inhibitors.
Shandong University
33
Design, synthesis and SAR studies of tripeptide analogs with the scaffold 3-phenylpropane-1,2-diamine as aminopeptidase N/CD13 inhibitors.
Shandong University
21
Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).
Shandong University
25
Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Shandong University
22
Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.
Shandong University
16
Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2.
Uppsala University
12
First synthesis of alpha-aminoalkyl-(N-substituted)thiocarbamoyl-phosphinates: inhibitors of aminopeptidase N (APN/CD13) with the new zinc-binding group.
Wroclaw University of Technology
19
Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Shandong University
30
Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Shandong University
33
Rational design, synthesis and pharmacological characterization of novel aminopeptidase A inhibitors.
Quantum Genomics
14
Design, synthesis, and biological evaluation of novel HDAC/CD13 dual inhibitors for the treatment of cancer.
Ocean University of China
14
Modulation of endogenous opioid signaling by inhibitors of puromycin-sensitive aminopeptidase.
University of Minnesota
26
ERAP Inhibitors in Autoimmunity and Immuno-Oncology: Medicinal Chemistry Insights.
University of Lille
22
Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.
Shandong University
37
Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents.
University of Lille
23
Novel hydroxamic acid-related phosphinates: inhibition of neutral aminopeptidase N (APN).
Wroclaw University of Technology
15
A library of novel hydroxamic acids targeting the metallo-protease family: design, parallel synthesis and screening.
University of Lille 2
5
Optimization of 1,2,4-Triazole-3-thiones toward Broad-Spectrum Metallo-β-lactamase Inhibitors Showing Potent Synergistic Activity on VIM- and NDM-1-Producing Clinical Isolates.
Univ Montpellier
47
Hydroxamic acid hybrids as the potential anticancer agents: An Overview.
Huaihe Hospital of Henan University
5
Phosphinate, sulfonate, and sulfonamidate dipeptides as potential inhibitors of Escherichia coli aminopeptidase N.
Miami University
147
Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities.
Central South University
21
Design, Synthesis, and Biological Evaluation of APN and AKT Dual-Target Inhibitors.
Shandong University
24
Discovery and Optimization of a Series of Benzofuran Selective ERAP1 Inhibitors: Biochemical and
Sanofi
6
Investigating the phosphinic acid tripeptide mimetic DG013A as a tool compound inhibitor of the M1-aminopeptidase ERAP1.
The Institute of Cancer Research
1
Synthesis and biological evaluation of novel flavone-8-acetic acid derivatives as reversible inhibitors of aminopeptidase N/CD13.
Institut Curie
2
Discovery of a novel chimeric ubenimex-gemcitabine with potent oral antitumor activity.
Shandong University
2
Discovery of BC-01, a novel mutual prodrug (hybrid drug) of ubenimex and fluorouracil as anticancer agent.
Shandong University
50
Novel Human Aminopeptidase N Inhibitors: Discovery and Optimization of Subsite Binding Interactions.
Monash University
21
Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors.
University of Antwerp (Uia)
3
Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases.
Monash University
40
Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.
Shandong University
11
Recent developments in the synthesis and applications of phosphinic peptide analogs.
Wroclaw University of Technology
14
Highly functionalized tetrahydropyridines are cytotoxic and selective inhibitors of human puromycin sensitive aminopeptidase.
Csir-Indian Institute of Chemical Technology
14
Differential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols.
University of Paris
33
Novel potent nonpeptide aminopeptidase N inhibitors with a cyclic imide skeleton.
University of Tokyo
14
New kelatorphan-related inhibitors of enkephalin metabolism: improved antinociceptive properties.
University of Paris
8
Synthesis and biological characterization of ubenimex-fluorouracil conjugates for anti-cancer therapy.
Shandong University
11
Puromycin based inhibitors of aminopeptidases for the potential treatment of hematologic malignancies.
University of Minnesota
42
Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry.
Shandong University
3
KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
Universidad De La Habana
6
Approaches towards the development of chimeric DPP4/ACE inhibitors for treating metabolic syndrome.
Ranbaxy Laboratories
8
Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitors
Centaurus Biopharma
34
Compounds as hypoxia mimetics, and compositions and uses thereof
Betta Pharmaceuticals
2
Combined X-ray, NMR, and kinetic analyses reveal uncommon binding characteristics of the hepatitis C virus NS3-NS4A protease inhibitor BI 201335.
Boehringer Ingelheim (Canada)